Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: A meta-analysis of randomized controlled trials

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Cavallaro, Giacomo ^a   Villamor Martínez, Eduardo ^b   Filippi, Luca ^c   Mosca, Fabio ^a   Villamor, Eduardo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

COMPLICATION; DIETARY SUPPLEMENT; HUMAN; META ANALYSIS; NEWBORN; PHYSIOLOGY; PREMATURITY; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; RISK FACTOR; SEPSIS;

DIETARY SUPPLEMENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PROBIOTICS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RETINOPATHY OF PREMATURITY; RISK ASSESSMENT; RISK FACTORS; SEPSIS;

EID: 85031283818     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-13465-2     Document Type: Article

References (68)

1. Fang, J. L. et al. Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis. Pediatrics 137, e20153387, https://doi. org/10. 1542/peds. 2015-3387 (2016).
2. Cavallaro, G. et al. The pathophysiology of retinopathy of prematurity: An update of previous and recent knowledge. Acta Ophthalmol 92, 2-20 (2014).
3. Lee, J. & Dammann, O. Perinatal infection, inflammation, and retinopathy of prematurity. Semin. Fetal Neonatal Med. 17, 26-29 (2012).
4. Hartnett, M. E. & Penn, J. S. Mechanisms and management of retinopathy of prematurity. N Engl J Med 367, 2515-2526 (2012).
5. Hartnett, M. E. & Lane, R. H. Effects of oxygen on the development and severity of retinopathy of prematurity. J. AAPOS. 17, 229-234 (2013).
6. Hartnett, M. E. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 122, 200-210 (2015).
7. Soetikno, B. T. et al. Inner retinal oxygen metabolism in the 50/10 oxygen-induced retinopathy model. Sci. Rep. 5, 16752 (2015).
8. Chen, J. & Smith, L. E. Retinopathy of prematurity. Angiogenesis 10, 133-140 (2007).
9. Chen, M. et al. Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity. Neonatology 99, 125-132 (2011).
10. Hauspurg, A. K. et al. Blood gases and retinopathy of prematurity: The ELGAN Study. Neonatology 99, 104-111 (2011).
11. Hellstrom, A. et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics 123, e638-645 (2009).
12. Au, S. C., Tang, S. M., Rong, S. S., Chen, L. J. & Yam, J. C. Association between hyperglycemia and retinopathy of prematurity: A systemic review and meta-analysis. Sci. Rep. 5, 9091 (2015).
13. Chan, P. Y. et al. Association of Gestational Hypertensive Disorders with Retinopathy of prematurity: A Systematic Review and Meta-analysis. Sci. Rep. 6, 30732 (2016).
14. Uddin, M. I. et al. In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy. Sci. Rep. 6, 31011 (2016).
15. Phelps, D. L., Lakatos, L. & Watts, J. L. D-Penicillamine for preventing retinopathy of prematurity in preterm infants. Cochrane Database Syst. Rev., CD001073 (2000).
16. Mihatsch, W. A. et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin. Nutr. 31, 6-15 (2012).
17. Zhou, P., Li, Y., Ma, L.-Y. & Lin, H.-C. The role of immunonutrients in the prevention of necrotizing enterocolitis in preterm very low birth weight infants. Nutrients 7, 7256-7270 (2015).
18. Hakansson, A. & Molin, G. Gut microbiota and inflammation. Nutrients 3, 637-682 (2011).
19. Ofek Shlomai, N., Deshpande, G., Rao, S. & Patole, S. Probiotics for preterm neonates: what will it take to change clinical practice Neonatology 105, 64-70 (2013).
20. Hardy, H., Harris, J., Lyon, E., Beal, J. & Foey, A. D. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5, 1869-1912 (2013).
21. Liu, Z., Liu, W., Ran, C., Hu, J. & Zhou, Z. Abrupt suspension of probiotics administration may increase host pathogen susceptibility by inducing gut dysbiosis. Sci. Rep. 6, 23214 (2016).
22. Agrawal, S., Rao, S. & Patole, S. Probiotic supplementation for preventing invasive fungal infections in preterm neonates-a systematic review and metaanalysis. Mycoses 58, 642-651 (2015).
23. Deshpande, G., Rao, S., Patole, S. & Bulsara, M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125, 921-930 (2010).
24. Guthmann, F., Kluthe, C. & Bührer, C. Probiotics for prevention of necrotising enterocolitis: An updated meta-analysis. Klin. Padiatr. 222, 284-290 (2010).
25. Sawh, S. C., Deshpande, S., Jansen, S., Reynaert, C. J. & Jones, P. M. Prevention of necrotizing enterocolitis with probiotics: A systematic review and meta-analysis. PeerJ. 4, e2429 (2016).
26. Rao, S. C., Athalye-Jape, G. K., Deshpande, G. C., Simmer, K. N. & Patole, S. K. Probiotic Supplementation and Late-Onset Sepsis in Preterm Infants: A Meta-analysis. Pediatrics 137, 1-16 (2016).
27. Baucells, B. J., Hally, M. M., Sánchez, A. T. Á. & Aloy, J. F. Probiotic associations in the prevention of necrotising enterocolitis and the reduction of late-onset sepsis and neonatal mortality in preterm infants under 1500g. A systematic review. An. Pediatr. 85, 247-255 (2016).
28. Billimoria, Z. C., Pandya, S., Bhatt, P. & Pandya, B. Probiotics-To Use, or Not to Use An Updated Meta-analysis. Clin. Pediatr. (Phila). 55, 1242-1244 (2016).
29. AlFaleh, K. & Anabrees, J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid. Based Child Health. 2014 9, 584-671 (2014).
30. Lau, C. S. & Chamberlain, R. S. Probiotic administration can prevent necrotizing enterocolitis in preterm infants: A meta-analysis. J. Pediatr. Surg. 50, 1405-1412 (2015).
31. Wang, Q., Dong, J. & Zhu, Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birthweight infants: An updated meta-analysis of 20 randomized, controlled trials. J. Pediatr. Surg. 47, 241-248 (2012).
32. Aceti, A. et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis. Ital. J. Pediatr. 41, 89 (2015).
33. Olsen, R., Greisen, G., Schroder, M. & Brok, J. Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies. Neonatology 109, 105-112 (2016).
34. Zhang, G. Q., Hu, H. J., Liu, C. Y., Shakya, S. & Li, Z. Y. Probiotics for Preventing Late-Onset Sepsis in Preterm Neonates: A PRISMACompliant Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) 95, e2581 (2016).
35. Mishra, V. et al. Probiotics as potential antioxidants: A systematic review. J. Agric. Food. Chem. 63, 3615-3626 (2015).
36. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 339, b2535 (2009).
37. Athalye-Jape, G., Deshpande, G., Rao, S. & Patole, S. Benefits of probiotics on enteral nutrition in preterm neonates: A systematic review. Am. J. Clin. Nutr. 100, 1508-19 (2014).
38. Aceti, A. et al. Probiotics and Time to Achieve Full Enteral Feeding in Human Milk-Fed and Formula-Fed Preterm Infants: Systematic Review and Meta-Analysis. Nutrients 8, 471 (2016).
39. Higgins, J. P. et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343, d5928 (2011).
40. Higgins, J. P. & Green, S. Cochrane handbook for systematic reviews of interventions. 2011. The Cochrane Collaboration 5 (2015).
41. Borenstein, M., Hedges, L. V., Higgins, J. & Rothstein, H. R. MetaRegression. Introduction to meta-analysis, 187-203 (2009).
42. Thompson, S. G. & Higgins, J. How should metaregression analyses be undertaken and interpreted Stat. Med. 21, 1559-1573 (2002).
43. Al-Hosni, M. et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J. Perinatol. 32, 253-259 (2012).
44. Chou, I. C. et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J. Pediatr. 156, 393-396 (2010).
45. Costeloe, K. et al. Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial. Lancet 387, 649-660 (2016).
46. Demirel, G., Erdeve, O., Celik, I. H. & Dilmen, U. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: A randomized, controlled study. Acta Paediatr. 102, e560-565 (2013).
47. Dilli, D. et al. The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J. Pediatr. 166, 545-551 e541 (2015).
48. Jacobs, S. E. et al. Probiotic effects on late-onset sepsis in very preterm infants: A randomized controlled trial. Pediatrics 132, 1055-1062 (2013).
49. Manzoni, P. et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clin. Infect. Dis. 42, 1735-1742 (2006).
50. Roy, A., Chaudhuri, J., Sarkar, D., Ghosh, P. & Chakraborty, S. Role of Enteric Supplementation of Probiotics on Late-onset Sepsis by Candida species in Preterm Low Birth Weight Neonates: A Randomized, Double Blind, Placebo-controlled Trial. N. Am. J. Med. Sci. 6, 50-57 (2014).
51. Sari, F. N. et al. Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants Am. J. Perinatol. 29, 579-586 (2012).
52. Totsu, S. et al. Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial. Pediatr. Int. 56, 714-719 (2014).
53. Manzoni, P. et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial. JAMA. 302, 1421-1428 (2009).
54. Fujii, T. et al. Bifidobacterium breve enhances transforming growth factor 1 signaling by regulating smad7 expression in preterm infants. J. Pediatr. Gastroenterol. Nutr. 43, 83-88 (2006).
55. Saengtawesin, V., Tangpolkaiwalsak, R. & Kanjanapattankul, W. Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants. J. Med. Assoc. Thai. 97, S20-25 (2014).
56. Li, D., Rosito, G. & Slagle, T. Probiotics for the prevention of necrotizing enterocolitis in neonates: An 8year retrospective cohort study. J. Clin. Pharm. Ther. 38, 445-449 (2013).
57. Higgins, R. D., Baker, C. J. & Raju, T. N. Executive summary of the workshop on infection in the high-risk infant. J. Perinatol. 30, 379-383 (2010).
58. Shah, J., Jefferies, A. L., Yoon, E. W., Lee, S. K. & Shah, P. S. Risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at >32 weeks' gestation. Am. J. Perinatol. 32, 675-682 (2015).
59. Abrahamsson, T. R. Not all probiotic strains prevent necrotising enterocolitis in premature infants. Lancet 387, 624-625 (2016).
60. Samuels, N. et al. Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: A quasi-experimental study. Sci. Rep. 6, 31643 (2016).
61. Thomas, J. P., Raine, T., Reddy, S. & Belteki, G. Probiotics for the prevention of necrotizing enterocolitis in verylowbirthweight infants: A metaanalysis and systematic review. Acta Paediatr (2017).
62. Tamburini, S., Shen, N., Wu, H. C. & Clemente, J. C. The microbiome in early life: implications for health outcomes. Nat Med 22, 713-722 (2016).
63. Dominguez-Bello, M. G. et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 22, 250-253 (2016).
64. Janvier, A., Malo, J. & Barrington, K. J. Cohort study of probiotics in a North American neonatal intensive care unit. J. Pediatr. 164, 980-985 (2014).
65. Neu, J. Routine probiotics for premature infants: let's be careful! J Pediatr. 158, 672-674 (2011).
66. Millar, M., Wilks, M., Fleming, P. & Costeloe, K. Should the use of probiotics in the preterm be routine Arch. Dis. Child Fetal Neonatal Ed. 97, F70-F74 (2012).
67. Modi, N. Probiotics and necrotising enterocolitis: The devil (as always) is in the detail. Neonatology 105, 71-73 (2013).
68. Neu, J. Necrotizing enterocolitis: The mystery goes on. Neonatology 106, 289-295 (2014).